SEC Form 6-K filed by Stratasys Ltd.

$SSYS
Computer peripheral equipment
Technology
Get the next $SSYS alert in real time by email
6-K 1 cover6-kq3x24pr.htm 6-K Document

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
 
For the month of November 2024
 
Commission File Number 001-35751
 
STRATASYS LTD.
(Translation of registrant’s name into English)
 
c/o Stratasys, Inc.
7665 Commerce Way
Eden Prairie, Minnesota 55344
 1 Holtzman Street, Science Park
P.O. Box 2496
Rehovot, Israel 76124
   
(Addresses of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
Form 20-F ☒      Form 40-F ☐
 
 
 
 
 
 




CONTENTS
 
Quarterly Results of Operations
 
On November 13, 2024, Stratasys Ltd. (“Stratasys”, “we” or “us”) announced our financial results for the third quarter and nine months ended September 30, 2024.  A copy of our press release announcing our results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (this “Form 6-K”) and is incorporated herein by reference.
 
In conjunction with the conference call being held on November 13, 2024 to discuss our results, we are furnishing a copy of the slide presentation that provides supplemental information regarding our business and our financial results, and which will be referenced on that conference call. We have attached that presentation to this Form 6-K as Exhibit 99.2, which exhibit is incorporated herein by reference.
 
The information in this Form 6-K, including Exhibits 99.1 and 99.2, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
 

Exhibits
 
The following exhibits are furnished as part of this Form 6-K:
 
 
 




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 STRATASYS LTD.
  
Dated: November 13, 2024
By:/s/ Eitan Zamir
 Name: Eitan Zamir
 Title:Chief Financial Officer
 

Get the next $SSYS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SSYS

DatePrice TargetRatingAnalyst
2/13/2024$24.00Overweight
Cantor Fitzgerald
1/4/2023$15.00Hold → Buy
Needham
11/8/2022Underperform → Mkt Perform
William Blair
8/17/2022$24.00Outperform
Credit Suisse
5/17/2022$25.00 → $23.00Underweight → Neutral
JP Morgan
2/24/2022$30.00Hold → Buy
Cross Research
11/4/2021Neutral → Underweight
JP Morgan
11/4/2021Overweight → Neutral
JP Morgan
More analyst ratings

$SSYS
Press Releases

Fastest customizable press release news feed in the world

See more
  • New York Embroidery Studio Unlocks New Levels of Creativity, Customization, and Sustainability with Stratasys 3D Fashion Solution

    The integration of Stratasys' J850 TechStyle™ solution empowers NYES to deliver innovative and sustainable fashion for global designers Stratasys (NASDAQ:SSYS) today announced that New York Embroidery Studio (NYES) has integrated the Stratasys J850 TechStyle™ printer into its manufacturing capabilities. Known for its innovation in design and production, NYES is leveraging this 3D Fashion® direct-to-textile printing technology to combine traditional embroidery with cutting-edge 3D printing, enabling new levels of creativity, personalization, and eco-conscious manufacturing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250218604

    $SSYS
    Computer peripheral equipment
    Technology
  • Stratasys Expands Market Opportunities for Medical Device Manufacturers to Leverage 3D Printing to Enhance Innovation and Improve Patient Outcomes

    Stratasys Direct's New ISO 13485 Certification Meets Stringent Regulatory Requirements Essential for Medical Device Manufacturers Stratasys Ltd. (NASDAQ:SSYS) today announced that its Stratasys Direct manufacturing facility in Tuscon, Arizona has achieved ISO 13485 certification, a globally recognized standard for quality management systems in medical device manufacturing. Stratasys plans to extend this certification to its other Stratasys Direct manufacturing facilities in Texas and Minnesota. By achieving ISO 13485 certification, Stratasys Direct is formally recognized for its safety, precision, and reliability of its 3D-printed components. This certification addresses critical regula

    $SSYS
    Computer peripheral equipment
    Technology
  • Stratasys Announces Unaudited Preliminary Approximate Fourth Quarter 2024 Financial Results

    Schedules Fourth Quarter 2024 Conference Call for 8:30 a.m. ET on Wednesday, March 5, 2025 Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced unaudited preliminary approximate financial results for the fourth quarter 2024. Preliminary Fourth Quarter 2024 Results Revenue of $150.1 to $150.5 million, with hardware sequentially higher and consumables sequentially lower compared to the third quarter of 2024 GAAP gross margin of 46.0% to 46.5%, non-GAAP gross margin of 49.4% to 49.7%. GAAP operating loss of $13.3 to $14.4 million, non-GAAP operating income of $9.0 to $9.5 million GAAP net loss of $15.3 to $16.5

    $SSYS
    Computer peripheral equipment
    Technology

$SSYS
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$SSYS
SEC Filings

See more

$SSYS
Leadership Updates

Live Leadership Updates

See more
  • Stratasys Announces $120 Million Equity Investment from Fortissimo Capital

    Transaction at a Premium Underscores Leading Position in the Additive Manufacturing Industry and Positions Stratasys to Drive Growth Strengthens Balance Sheet to Capture Market Opportunities Fortissimo's Founding and Managing Partner, Yuval Cohen, to Join the Stratasys Board Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced that Fortissimo Capital ("Fortissimo"), a leading Israeli private equity fund investing in technology and industrials, has entered into an agreement to invest $120 million in the Company, acquiring approximately 14% of Stratasys' issued and outstanding ordinary shares through a direct purchase of

    $SSYS
    Computer peripheral equipment
    Technology
  • Stratasys Publishes Third ESG and Sustainability Report; Advances Leadership in Sustainable Additive Manufacturing

    Stratasys highlights achievements in environmental, social, and governance initiatives, cementing its position as a supplier of choice for sustainable AM-enabled production solutions. Stratasys Ltd. (NASDAQ:SSYS) today announced the publication of its third Mindful Manufacturing™ ESG (Environment, Social, and Governance) and Sustainability Report. Prepared in accordance with the Global Reporting Initiative (GRI) and referencing SASB (Sustainability Accounting Standards Board) standards, the report underscores Stratasys' commitment to ESG excellence and enterprise risk management through best-in-class corporate governance, a people-first approach, meaningful social impact, and robust envir

    $SSYS
    Computer peripheral equipment
    Technology
  • Stratasys Expands Access to Anatomical Realism with New Digital Anatomy Solution

    Medical facilities and device manufacturers previously limited by constraints can now create patient-specific models to enhance surgical preparation, elevate patient outcomes, and fast-track innovation Stratasys Ltd. (NASDAQ:SSYS) today announced the launch of its J5™ Digital Anatomy™ 3D printer, the latest innovation designed to address the growing demand for cost-effective, high-fidelity anatomical models. This Stratasys innovation is designed to enable hospitals, medical device manufacturers and research institutions to enhance patient outcomes, streamline operations and bring products to market faster. This press release features multimedia. View the full release here: https://www.bu

    $SSYS
    Computer peripheral equipment
    Technology

$SSYS
Financials

Live finance-specific insights

See more
  • Stratasys Announces Unaudited Preliminary Approximate Fourth Quarter 2024 Financial Results

    Schedules Fourth Quarter 2024 Conference Call for 8:30 a.m. ET on Wednesday, March 5, 2025 Stratasys Ltd. (NASDAQ:SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced unaudited preliminary approximate financial results for the fourth quarter 2024. Preliminary Fourth Quarter 2024 Results Revenue of $150.1 to $150.5 million, with hardware sequentially higher and consumables sequentially lower compared to the third quarter of 2024 GAAP gross margin of 46.0% to 46.5%, non-GAAP gross margin of 49.4% to 49.7%. GAAP operating loss of $13.3 to $14.4 million, non-GAAP operating income of $9.0 to $9.5 million GAAP net loss of $15.3 to $16.5

    $SSYS
    Computer peripheral equipment
    Technology
  • COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

    -Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and rapid ingrowth of native tissue -Innovative breast implant technology designed to address a $3.0 billion market opportunity -Cash and cash equivalents balance as of September 30, 2024 was $15.4 million -Conference call to be held today at 10:00 a.m. U.S. EDT – REHOVOT, Israel, Nov. 27, 2024 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration

    $CLGN
    $SSYS
    Industrial Specialties
    Health Care
    Computer peripheral equipment
    Technology
  • Stratasys Releases Third Quarter 2024 Financial Results

     Raises 2024 Margins and Profitability Outlook Revenue of $140.0 million, compared to $162.1 million in third quarter 2023 Eighth consecutive quarter of year-over-year growth in recurring consumables revenue reflects continued strong printer utilization Improved GAAP gross margin by 430bps to 44.8% and non-GAAP gross margin by 130bps to 49.6% compared to third quarter 2023 GAAP net loss of $26.6 million, or $0.37 per diluted share; non-GAAP net income resumes achieving profitability with $0.4 million, or $0.01 per diluted share $4.5 million of cash used in operations; year-to-date operating cash flow remains positive Adjusted EBITDA of $5.1 million Restructuring cost sa

    $SSYS
    Computer peripheral equipment
    Technology

$SSYS
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more